Document Detail


Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.
MedLine Citation:
PMID:  3558985     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The mechanisms of action of the potent antiarrhythmic drug amiodarone are unknown. However, amiodarone and its abundant metabolite, desethylamiodarone, bear a striking structural resemblance to thyroid hormones. In addition, certain cardiac electrophysiologic effects of amiodarone treatment are similar to those of hypothyroidism. These facts suggest that amiodarone or desethylamiodarone could be acting, in part, by blocking thyroid hormone action. Because thyroid hormones are known to act through nuclear receptor proteins, the binding of amiodarone and desethylamiodarone was measured to nuclear extracts derived from human lymphocytes, bovine atrium and ventricle and rat liver. The capacity of increasing concentrations of amiodarone and desethylamiodarone nuclear extracts to block receptor binding of radiolabeled triiodothyronine (T3) in a standard in vitro competition assay was tested. Nuclear extracts demonstrated only minimal binding to amiodarone. However, all receptor preparations had substantial affinities (KD) for the desethyl analog: lymphocyte, 8.6 microM; atrium, 35.0 microM; ventricle, 26.9 microM and liver, 8.6 microM. Desethylamiodarone accumulates in very large quantities in parenchymatous organs during long-term amiodarone treatment. Taking its usual therapeutic serum level (about 4 microM or 2.7 micrograms/ml) as an estimate of intranuclear concentration, desethylamiodarone would partially saturate nuclear thyroid hormone receptors in several different tissues, including the heart. Thus, amiodarone treatment may exert some of its electrophysiologic effects by metabolic conversion to desethylamiodarone. This metabolite may then exclude thyroid hormone from nuclear receptor sites within the myocardium.
Authors:
K R Latham; D F Sellitti; R E Goldstein
Related Documents :
8330325 - Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p...
7893345 - In vitro binding of 3,5-di-iodo-l-thyronine to rat liver mitochondria.
1726785 - The extracellular domain of the tsh receptor has an immunogenic epitope reactive with g...
947615 - Comparison between human 125i-labelled tsh labelled with lactoperoxidase or chloramine-...
7929325 - A kinetic model for oxotremorine m binding to recombinant porcine m2 muscarinic recepto...
11676925 - Sprap1 and sprif1, recruited to telomeres by taz1, are essential for telomere function ...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  9     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1987 Apr 
Date Detail:
Created Date:  1987-04-27     Completed Date:  1987-04-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  872-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / analogs & derivatives*,  metabolism*
Animals
Binding, Competitive
Cattle
Chemical Phenomena
Chemistry
Drug Interactions
Humans
Liver / metabolism
Lymphocytes / metabolism
Myocardium / metabolism
Rats
Receptors, Thyroid Hormone / metabolism*
Structure-Activity Relationship
Triiodothyronine / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Receptors, Thyroid Hormone; 1951-25-3/Amiodarone; 6893-02-3/Triiodothyronine; 83409-32-9/desethylamiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart fail...
Next Document:  Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ven...